Influx Healthtech IPO Details: Influx Healthtech Limited is set to launch its IPO on June 18, 2025, with the issue closing on June 20, 2025. This is a book-built issue aimed at raising approximately ₹58.57 crore, which includes a fresh issue worth ₹48.00 crore and an offer for sale (OFS) of up to 11,00,400 equity shares, each with a face value of ₹10.
The IPO price band has been fixed at ₹91 to ₹96 per share. The allocation is structured with 50% reserved for Qualified Institutional Buyers (QIBs), 15% for High Net-worth Individuals (HNIs), and 35% for retail investors.
The basis of allotment is expected to be finalized on June 23, 2025, and the IPO is scheduled to list on the NSE on June 25, 2025.
From a financial standpoint, Influx Healthtech reported a revenue of ₹104.99 crore in FY 2025, up from ₹100.10 crore in FY 2024. Net profit also rose to ₹13.37 crore in FY 2025 from ₹11.22 crore in the previous year.
Given the company’s consistent growth in both revenue and profitability, the IPO appears promising for long-term investors.
Influx Healthtech IPO Objectives:
- Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division
- Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division
- Purchase of Machineries for Homecare and Cosmetic Division
- General corporate purposes.
Influx Healthtech IPO Review (Apply or Not)
- Update soon
Influx Healthtech IPO Date & Price Band Details:
| IPO Open Date: | June 18, 2025 |
| IPO Close Date: | June 20, 2025 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹91 to ₹96 Per Share |
| Issue Size: | Approx ₹58.57 Crores |
| Fresh Issue: | Approx ₹48.00 Crores |
| Offer for Sale: | Approx 11,00,400 Equity Shares |
| Issue Type: | Book Build Issue |
| IPO Listing: | NSE SME |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Influx Healthtech IPO Lot Size:
The minimum lot size for the Influx Healthtech IPO is 1,200 shares, requiring a total application amount of ₹1,15,200 for retail investors.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 1200 | ₹1,15,200 |
| Retail Maximum | 1 | 1200 | ₹1,15,200 |
| S-HNI Minimum | 2 | 2,400 | ₹2,30,400 |
Influx Healthtech IPO Allotment & Listing Date (Details)
The Influx Healthtech IPO will open for subscription on June 18, 2025, and close on June 20, 2025. The allotment of shares is expected to be finalized on June 23, 2025, with the IPO listing scheduled for June 25, 2025.
| IPO Open Date: | June 18, 2025 |
| IPO Close Date: | June 20, 2025 |
| Basis of Allotment: | June 23, 2025 |
| Refunds: | June 24, 2025 |
| Credit to Demat Account: | June 24, 2025 |
| IPO Listing Date: | June 25, 2025 |
Influx Healthtech IPO GMP Today:
the latest GMP (Grey Market Premium) for the Influx Healthtech SME IPO stands at ₹18. Based on the upper price band of ₹96.00, the estimated listing price is projected to be around ₹114 (i.e., cap price + GMP). This suggests a potential listing gain of approximately 18.75% per share
Promoters of Influx Healthtech IPO
The promoters of the company are Mr. Munir Abdul Ganee Chandniwala, Mrs. Shirin Munir Ahmed Chandniwala and Mr. Abdul Ganee Abdul Rasul Chandniwala.
About Influx Healthtech IPO
Influx Healthtech Limited, founded in 2020, is a leading healthcare-focused company specializing in contract manufacturing. The company has built a strong reputation as a trusted Contract Development and Manufacturing Organization (CDMO), offering expert services to clients from various industries. The company comprises manufacturing units in Thane, Maharashtra, with areas of around 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft. The company is known to manufacture its products while keeping safety, quality, and compliance with regulations. Influx Healthcare works in different areas like dietary and nutritional supplements, cosmetics, ayurvedic/herbal products, veterinary feed supplements, and homecare items. The CDMO business caters to many major clients like Bling Brands, Pursuit of Wellness, Aarkios Health, HSHS Nutraceuticals Limited, Novus Life Science, Bruder Life Science, Fredun Pharmaceuticals, and BigFlex Lifescience. As of now, the company includes 165 permanent staff.
Influx Healthtech IPO Company Financial Report
The company reported revenue of ₹104.99 crores in 2025 against ₹100.10 crore in 2024. The company reported profit of ₹13.37 crores in 2025 against profit of ₹11.22 crores in 2024.
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2023 | ₹76.06 | ₹66.32 | ₹7.20 | ₹28.30 |
| 2024 | ₹100.02 | ₹85.08 | ₹11.13 | ₹41.10 |
| 2025 | ₹104.99 | ₹87.11 | ₹13.37 | ₹70.30 |
Influx Healthtech IPO Valuation – FY2025
Check Influx Healthtech IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 36.98% |
| ROCE: | 49.17% |
| EBITDA Margin: | 19.62% |
| PAT Margin: | 12.75% |
| Debt to equity ratio: | 0.01 |
| Earning Per Share (EPS): | ₹7.36 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 36.98% |
| Net Asset Value (NAV): | ₹19.91 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Sudarshan Pharma Industries Limited | 0.66 | 48.28 | 12.45% | 5.30 | 505.38 Cr. |
| Quest Laboratories Limited | 8.28 | 10.38 | 16.58% | 49.92 | 108.16 Cr. |
Influx Healthtech IPO Registrar
Maashitla Securities Private Limited
Phone: +91-11-45121795-96
Email: investor.ipo@maashitla.com
Website: https://maashitla.com/allotment-status/public-issues
IPO Lead Managers aka Merchant Bankers
- Rarever Financial Advisors Pvt. Ltd. Pvt. Ltd.
Company Address
Influx Healthtech Limited
109, Ghanshyam Enclave Premises Co-op
Soc Plot No. 856, Laljipada
Kandivali West,
Mumbai, Maharashtra
Phone: +91 7045997809
Email: cs@influxhealthtech.com
Website: https://influxhealthtech.com/
Influx Healthtech IPO – Frequently Asked Questions (FAQs)
What is Influx Healthtech IPO?
Influx Healthtech IPO is an SME public offering aiming to raise approximately ₹58.57 crore. The IPO is priced in the range of ₹91 to ₹96 per equity share and is proposed to be listed on the NSE SME platform.
When will Influx Healthtech IPO open for subscription?
The IPO will open for subscription on June 18, 2025, and will close on June 20, 2025. It is available for QIBs, NIIs, and retail investors.
What is the investor quota in Influx Healthtech IPO?
The allocation is as follows:
- Qualified Institutional Buyers (QIBs): 50%
- Non-Institutional Investors (NIIs): 15%
- Retail Individual Investors (RIIs): 35%
How can I apply for the Influx Healthtech IPO?
You can apply through:
- ASBA via your bank’s net banking platform
- UPI through online platforms provided by stock brokers
- Offline by submitting a physical application form through your broker
What is the issue size of the Influx Healthtech IPO?
The total issue size is approximately ₹58.57 crore, which includes a fresh issue of ₹48.00 crore and an offer for sale (OFS) of 11,00,400 equity shares.
What is the price band for the IPO?
The price band for the Influx Healthtech IPO is set at ₹91 to ₹96 per share.
What is the minimum lot size for the Influx Healthtech IPO?
Investors need to apply for a minimum of 1,200 shares, amounting to an investment of ₹1,15,200.
What is the allotment date for Influx Healthtech IPO?
The basis of allotment is expected to be finalized on June 23, 2025.
When is the Influx Healthtech IPO listing date?
The shares are scheduled to be listed on the NSE SME platform on June 25, 2025.
